Healthcare -
Biotechnology - NASDAQ - US
$ 3.35
0.601 %
$ 2.33 M
Market Cap
0.0
P/E
RNAZ - OPERATING INCOME
Operating Income RNAZ - TransCode Therapeutics, Inc.
-19.4 M
LAST VALUE
-77.68%
2 YEAR CAGR
-119.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR